Hany Massarany - Mar 31, 2023 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Director
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Hany Massarany
Stock symbol
BDSX
Transactions as of
Mar 31, 2023
Transactions value $
$0
Form type
4
Date filed
4/4/2023, 04:39 PM
Previous filing
Jan 5, 2023
Next filing
May 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +146K +105.73% 284K Mar 31, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Options Exercise $0 -146K -95.6% $0.00 6.71K Mar 31, 2023 Common Stock 146K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 These RSUs vested in full on March 31, 2023.
F3 This amount includes 6,707 deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer.